Reading time: 5 minutes Nayela Chowdhury Pancreatic ductal adenocarcinoma (PDAC) is an exocrine tumor of the pancreas and constitutes up to 95% of all pancreatic cancer cases. PDAC exhibits one of the poorest prognosis of all solid cancers and is associated with a very low overall and progression-free survival rate. Even though many molecular pathways... Continue Reading →
Post Mastectomy Choices: Exploring the Link Between Breast Implants and Cancer
Reading time: 5 minutes Nayela Chowdhury Breast cancer is a significant health concern affecting millions of people worldwide. In 2023, around 43,000 mortalities are projected to occur in the United States alone. Mastectomy is the primary curative therapy for breast cancer and involves the surgical removal of one or both of the breasts. Millions of... Continue Reading →
Tumor-on-a-chip: A Better Method for Drug Discovery?
Reading time: 7 minutes Nayela Chowdhury Conventional 2D and 3D models of cancer have widely been utilized in pre-clinical drug development; however, neither of the platforms mimics the dynamic interactions that occur in living tumors. In vivo studies (for example, in small animal models) have been central in translational cancer research and have contributed largely... Continue Reading →
